V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 300004412 | 300003093 | 1.72 | 72 | Curative (C) | 2013-01-18 | 2013-02-06 | CARBOPLATIN + CETUXIMAB + FU | N | N | 300023623 | TEMOZOLOMIDE + RT |
| 300004413 | 300003094 | 1.72 | 88 | Curative (C) | 2017-02-14 | 2017-02-27 | ESPAC-4 TRIAL | 02 | N | 300023635 | CYCLOPHOSPHAMIDE + GEMCITABINE + RITUXIMAB + VINCRISTINE |
| 300004414 | 300003095 | 1.8 | 67.6 | Neo-adjuvant (N) | 2017-02-15 | 2017-02-28 | Cisplatin + Fluorouracil + RT 5day | 01 | N | 300023640 | CAPECITABINE + GEMCITABINE |
| 300004415 | 300003096 | 1.67 | null | Neo-adjuvant (N) | 2015-03-08 | 2015-03-18 | FLUOROURACIL | 02 | N | 300023651 | FLUOROURACIL + MITOMYCIN + RT |
| 300004416 | 300006118 | 1.48 | 0 | Palliative (P) | 2018-04-11 | 2018-04-21 | FLUOROURACIL + MITOMYCIN | N | N | 300023652 | CVP R |
| 300004417 | 300003097 | 1.61 | 61 | Adjuvant (A) | 2013-11-27 | 2013-11-27 | null | 2 | N | 300023653 | CISPLATIN + PEMETREXED |
| 300004418 | 300003098 | null | 71.3 | Palliative (P) | 2016-04-04 | 2016-04-05 | Bevacizumab | null | null | 300023656 | HYDROXYCARBAMIDE |
| 300004419 | 300003099 | 1.65 | 76.3 | Palliative (P) | 2014-12-25 | 2015-01-21 | CAPECITABINE + OXALIPLATIN | 02 | Y | 300023658 | BENDAMUSTINE + RITUXIMAB |
| 300004420 | 300003099 | 1.76 | 72.52 | Adjuvant (A) | 2014-02-18 | 2014-02-22 | Vinblastine weekly | 02 | N | 300023658 | FLUOROURACIL |
| 300004421 | 300003099 | 1.6 | 47 | Curative (C) | 2014-07-13 | 2014-07-14 | GemCarbo Days 1+8 | 2 | null | 300023658 | ESPAC TRIAL |
| 300004422 | 300003100 | 1.9 | 42.4 | Palliative (P) | null | 2015-02-06 | FLUOROURACIL + OXALIPLATIN | N | N | 300023674 | BEVACIZUMAB |
| 300004423 | 300003101 | 1.66 | null | Not known (9) | 2015-02-08 | 2015-02-17 | CAPECITABINE + GEMCITABINE | null | null | 300023679 | CAPECITABINE + RT |
| 300004424 | 300003102 | 1.65 | 84.7 | Palliative (P) | 2016-01-19 | 2016-01-29 | Fluorouracil+Mitomycin+RT (Anal Ca) | 2 | N | 300023683 | CETUXIMAB + CISPLATIN + FU |
| 300004425 | 300003103 | 1.81 | 89.8 | Palliative (P) | 2016-11-02 | 2016-11-03 | CARBOPLATIN + RT | 01 | N | 300023684 | CARBO + FLUOROURACIL |
| 300004426 | 300003104 | 1.8 | 86 | Palliative (P) | null | 2013-06-27 | CARBOPLATIN + Cetuximab + FLUOROURACIL | N | N | 300023685 | CARBOPLATIN + ETOPOSIDE |
| 300004427 | 300003105 | null | 62.3 | Curative (C) | 2014-03-01 | 2014-03-01 | Carboplatin AUC 2 - 5 | 2 | N | 300023689 | PEMBROLIZUMAB |
| 300004428 | 300003105 | 1.61 | 57.8 | Curative (C) | 2017-09-28 | 2017-10-04 | CARBOPLATIN + ETOPOSIDE | N | N | 300023689 | CARBOPLATIN + DOCETAXEL + FLUOROURACIL |
| 300004429 | 300003105 | 1.61 | 78.2 | Curative (C) | 2015-08-12 | 2015-09-01 | Fluorouracil+Mitomycin+RT (Anal Ca) | N | N | 300023689 | CISPLATIN + FLUOROURACIL + RT |
| 300004430 | 300003106 | 1.66 | 120 | null | 2016-09-18 | 2016-10-01 | CompARE Trial | N | N | 300023705 | FCR |
| 300004431 | 300003106 | null | 74.2 | Neo-adjuvant (N) | 2015-01-08 | 2015-01-14 | FLUOROURACIL + MITOMYCIN + RT | 01 | N | 300023705 | FLUOROURACIL + MITOMYCIN + RT |
| 300004432 | 300003106 | 1.62 | 69 | Curative (C) | 2014-12-30 | 2015-01-09 | VAI (Ifos 3g/m2) | N | Y | 300023705 | PRICKLE TRIAL |
| 300004433 | 300003106 | 1.79 | 82.6 | Curative (C) | 2014-08-22 | 2014-09-03 | Capecitabine 35days + RT | 02 | Y | 300023705 | CAPECITABINE + OXALIPLATIN |
| 300004434 | 300003107 | 1.62 | 62.5 | Curative (C) | 2015-08-23 | 2015-08-28 | FEC 100 | 01 | N | 300023725 | CARBOPLATIN + RT |
| 300004435 | 300003108 | null | 69.8 | Neo-adjuvant (N) | 2016-01-27 | 2016-02-03 | Cisplatin + Etoposide (3 day) | 02 | null | 300023731 | CARBOPLATIN + ETOPOSIDE |
| 300004438 | 300003111 | 1.56 | 74.9 | Curative (C) | 2015-08-02 | 2015-08-13 | CARBOPLATIN | 02 | N | 300023755 | FLUOROURACIL + MITOMYCIN |
| 300004440 | 300003113 | 1.8 | null | null | 2016-03-27 | 2016-04-06 | CARBOPLATIN + RT | 02 | Y | 300023775 | OXALIPLATIN + MDG |
| 300004441 | 300003114 | 1.7 | 74.2 | Palliative (P) | 2017-03-02 | 2017-03-27 | CARBOPLATIN + ETOPOSIDE | null | Y | 300023780 | COMPARE TRIAL |
| 300004443 | 300003116 | 1.72 | 70 | Curative (C) | 2016-03-20 | 2016-03-22 | FLUOROURACIL + MITOMYCIN | 02 | null | 300023787 | CARBOPLATIN + RT |
| 300004445 | 300003118 | 1.63 | null | Curative (C) | 2017-10-17 | 2017-10-30 | Dacarbazine | 2 | null | 300023789 | PACLITAXEL |
| 300004446 | 300003119 | 1.8 | 55.5 | Curative (C) | 2015-01-13 | 2015-02-04 | BLEOMYCIN | N | N | 300023792 | PACLITAXEL |
| 300004447 | 300003120 | 1.51 | 65.2 | Not known (9) | 2014-09-29 | 2014-10-10 | FLUOROURACIL + MITOMYCIN | 2 | N | 300023793 | FLUOROURACIL + MITOMYCIN |
| 300004448 | 300003121 | 1.71 | null | Adjuvant (A) | 2015-04-25 | 2015-05-22 | Cisplatin + Paclitaxel | null | Y | 300023794 | CAPECITABINE + OXALIPLATIN |
| 300004449 | 300003121 | 1.56 | 67.3 | Adjuvant (A) | 2018-01-17 | 2018-01-21 | CARBOPLATIN + RT | 01 | N | 300023794 | FLUOROURACIL + MITOMYCIN |
| 300004450 | 300003121 | 1.8 | 76.8 | Palliative (P) | 2016-11-08 | 2016-11-08 | CAPECITABINE + OXALIPLATIN | 2 | N | 300023794 | CARBOPLATIN + RT |
| 300004451 | 300003121 | 1.49 | 76.3 | Curative (C) | 2017-11-23 | 2017-12-09 | FLUOROURACIL | 01 | N | 300023794 | FLUOROURACIL |
| 300004452 | 300003121 | 1.73 | 74.55 | null | null | 2017-10-16 | DE-ESCALATE TRIAL | null | null | 300023794 | CTD |
| 300004453 | 300003122 | 1.56 | 65.2 | Palliative (P) | 2016-12-29 | 2017-01-05 | CAPECITABINE + GEMCITABINE | N | N | 300023814 | CISPLATIN + FLUOROURACIL + RT |
| 300004458 | 300006124 | 1.57 | 88 | Curative (C) | 2016-08-18 | 2016-09-22 | CompARE Trial | N | N | 300023837 | CARBOPLATIN |
| 300004459 | 300003126 | 1.74 | 94 | Adjuvant (A) | 2016-07-18 | 2016-07-24 | Carboplatin + Etoposide iv&po | 02 | N | 300023840 | CARBOPLATIN |
| 300004460 | 300003127 | 1.79 | 82 | null | 2013-04-13 | 2013-05-02 | CARBOPLATIN + RT | N | N | 300023844 | CARBOPLATIN + RT |
| 300004461 | 300003128 | null | null | Palliative (P) | 2016-07-16 | 2016-07-23 | ESPAC-4 TRIAL | N | N | 300023846 | EP |
| 300004462 | 300003128 | null | 72 | Palliative (P) | 2017-04-02 | 2017-04-09 | CHOP R - 21 days | N | N | 300023846 | CAPECITABINE + OXALIPLATIN |
| 300004463 | 300003128 | 1.74 | 81 | Curative (C) | 2014-12-30 | 2014-12-31 | GemCarbo Days 1+8 | 2 | Y | 300023846 | GEMCARBO |
| 300004464 | 300003129 | 1.64 | 62.1 | Curative (C) | 2016-12-26 | 2017-01-22 | PEMBROLIZUMAB | Y | Y | 300023857 | CAPECITABINE + GEMCITABINE |
| 300004465 | 300003129 | 1.65 | 73.4 | Palliative (P) | 2015-01-01 | 2015-01-13 | CISPLATIN + FLUOROURACIL + RT | N | N | 300023857 | ESPAC TRIAL |
| 300004466 | 300003130 | 1.62 | 72.8 | Adjuvant (A) | 2013-04-25 | 2013-04-26 | CARBOPLATIN + RT | 02 | null | 300023868 | DARS TRIAL |
| 300004467 | 300003131 | null | null | Palliative (P) | 2016-09-16 | 2016-09-18 | GEMCARBO | 2 | N | 300023872 | CAPECITABINE + GEMCITABINE |
| 300004468 | 300003131 | 1.78 | 97 | Adjuvant (A) | 2013-09-30 | 2013-09-30 | CARBOPLATIN + DOCETAXEL + FLUOROURACIL | 02 | N | 300023872 | CARBOPLATIN + RT |
| 300004469 | 300003132 | 1.8 | 106.6 | Palliative (P) | 2018-04-26 | 2018-05-18 | CARBOPLATIN + RT | N | N | 300023885 | ICON TRIAL |
| 300004470 | 300003132 | 1.49 | 70 | Palliative (P) | 2014-08-30 | 2014-09-13 | FLUOROURACIL + MITOMYCIN | N | N | 300023885 | CARBOPLATIN |